TLM Utility Nav

Transforming the Future of Hepatology: Clinical Research Innovations That Improve Diagnostic Methods, Trial Design, and Patient Outcomes, Part 1

Description

This 2-part workshop is dedicated to fostering innovation and collaboration in hepatology research. In part 1, invited talks led by top experts introduce attendees to forward-thinking perspectives on essential research aspects—including cohort design, biomarker development, and clinical trials—providing a rich base for informed conversations. Part 2 deepens the discussions in breakout sessions where experts and junior faculty jointly tackle practical issues of cohort development, biomarker development, and clinical trials. This workshop promises a stimulating environment for attendees to engage in robust discussions and learn from each other with the goal of driving improvements in hepatology research and, ultimately, patient outcomes.

Presentations

2:00 PM - 2:20 PM
Nov 18 2024
San Diego, CA

Constructing and Optimizing Clinical Cohorts: Unveiling the Blueprint for Exceptional Clinical Research With Lessons From the Alcoholic Hepatitis Network

Vijay H. Shah, MD, FAASLD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
2:20 PM - 2:40 PM
Nov 18 2024
San Diego, CA

Decoding Portal Hypertension in Cirrhosis: Unpacking Lessons and Insights From Portal Hypertension Trials

Guadalupe Garcia-Tsao, MD, FAASLD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
2:40 PM - 3:00 PM
Nov 18 2024
San Diego, CA

Trailblazing Translational Research: Unveiling, Validating, and Implementing Novel Diagnostics to Optimize Liver Transplant for Hepatocellular Carcinoma

Jorge Marrero, MD, FAASLD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
3:00 PM - 3:20 PM
Nov 18 2024
San Diego, CA

Q&A

Christine C Hsu, MD, Moderator
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD

Objectives

  • Describe how to build a cohort for clinical research.
  • Identify how to leverage translational research or biomarkers to improve patient clinical outcomes in liver transplantation.
  • Review how to optimize study designs and endpoints, and overcome pitfalls in clinical trial design in portal hypertension.
Chair

Giuseppe Cullaro, MD

Columbia University